Joshua D Bernstock1, Zachary Wright2, Asim K Bag3, Florian Gessler4, George Yancey Gillespie5, James M Markert5, Gregory K Friedman6, James M Johnston2. 1. Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA. 2. Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. 3. Department of Radiology, Neuroradiology Section, University of Alabama at Birmingham, Birmingham, Alabama, USA. 4. Department of Neurosurgery, Goethe University Frankfurt, Frankfurt am Main, Germany. 5. Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. 6. Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: gfriedman@peds.uab.edu.
Abstract
OBJECTIVE: The engineered herpes simplex virus-1 G207, is a promising therapeutic option for central nervous system tumors. The first-ever pediatric phase 1 trial of continuous-infusion delivery of G207 via intratumoral catheters for recurrent or progressive malignant brain tumors is ongoing. In this article, we describe surgical techniques for the accurate placement of catheters in multiple supratentorial locations and perioperative complications associated with such procedures. METHODS: A prospective study of G207 in children with recurrent malignant supratentorial tumors is ongoing. Preoperative stereotactic protocol magnetic resonance imaging was performed, and catheter trajectories planned using StealthStation planning software. Children underwent placement of 3-4 silastic catheters using a small incision burr hole and the Vertek system. Patients had a preinfusion computed tomography scan to confirm correct placement of catheters. RESULTS: Six children underwent implantation of 3-4 catheters. Locations of catheter placement included frontal, temporal, parietal, and occipital lobes, and the insula and thalamus. There were no clinically significant perioperative complications. Postoperative computed tomography scans coupled with preoperative MRI scans demonstrated accurate placement of 21 of 22 catheters, with 1 misplaced catheter pulled back to an optimal location at the bedside. One patient had hemorrhage along the catheter tract that was clinically asymptomatic. Another patient had cerebrospinal fluid leak from a biopsy incision 9 days after surgery that was oversewn without complication. CONCLUSIONS: The placement of multiple intratumoral catheters in pediatric patients with supratentorial tumors via frameless stereotactic techniques is feasible and safe. Intratumoral catheters provide a potentially effective route for the delivery of G207 and may be employed in other trials utilizing oncolytic virotherapy for brain tumors.
OBJECTIVE: The engineered herpes simplex virus-1 G207, is a promising therapeutic option for central nervous system tumors. The first-ever pediatric phase 1 trial of continuous-infusion delivery of G207 via intratumoral catheters for recurrent or progressive malignant brain tumors is ongoing. In this article, we describe surgical techniques for the accurate placement of catheters in multiple supratentorial locations and perioperative complications associated with such procedures. METHODS: A prospective study of G207 in children with recurrent malignant supratentorial tumors is ongoing. Preoperative stereotactic protocol magnetic resonance imaging was performed, and catheter trajectories planned using StealthStation planning software. Children underwent placement of 3-4 silastic catheters using a small incision burr hole and the Vertek system. Patients had a preinfusion computed tomography scan to confirm correct placement of catheters. RESULTS: Six children underwent implantation of 3-4 catheters. Locations of catheter placement included frontal, temporal, parietal, and occipital lobes, and the insula and thalamus. There were no clinically significant perioperative complications. Postoperative computed tomography scans coupled with preoperative MRI scans demonstrated accurate placement of 21 of 22 catheters, with 1 misplaced catheter pulled back to an optimal location at the bedside. One patient had hemorrhage along the catheter tract that was clinically asymptomatic. Another patient had cerebrospinal fluid leak from a biopsy incision 9 days after surgery that was oversewn without complication. CONCLUSIONS: The placement of multiple intratumoral catheters in pediatric patients with supratentorial tumors via frameless stereotactic techniques is feasible and safe. Intratumoral catheters provide a potentially effective route for the delivery of G207 and may be employed in other trials utilizing oncolytic virotherapy for brain tumors.
Authors: J M Markert; M D Medlock; S D Rabkin; G Y Gillespie; T Todo; W D Hunter; C A Palmer; F Feigenbaum; C Tornatore; F Tufaro; R L Martuza Journal: Gene Ther Date: 2000-05 Impact factor: 5.250
Authors: Ondrej Bradac; Anna Steklacova; Katerina Nebrenska; Jiri Vrana; Patricia de Lacy; Vladimir Benes Journal: World Neurosurg Date: 2017-04-25 Impact factor: 2.104
Authors: David Ruano; José A López-Martín; Lucas Moreno; Álvaro Lassaletta; Francisco Bautista; Maitane Andión; Carmen Hernández; África González-Murillo; Gustavo Melen; Ramón Alemany; Luis Madero; Javier García-Castro; Manuel Ramírez Journal: Mol Ther Date: 2020-01-21 Impact factor: 11.454
Authors: Joshua D Bernstock; Asim K Bag; John Fiveash; Kara Kachurak; Galal Elsayed; Gustavo Chagoya; Florian Gessler; Pablo A Valdes; Avi Madan-Swain; Richard Whitley; James M Markert; G Yancey Gillespie; James M Johnston; Gregory K Friedman Journal: Hum Gene Ther Date: 2020-08-17 Impact factor: 5.695
Authors: Stacie K Totsch; Charles Schlappi; Kyung-Don Kang; Andrew S Ishizuka; Geoffrey M Lynn; Brandon Fox; Elizabeth A Beierle; Richard J Whitley; James M Markert; G Yancey Gillespie; Joshua D Bernstock; Gregory K Friedman Journal: Oncogene Date: 2019-07-09 Impact factor: 8.756
Authors: Yoshihiro Otani; Ji Young Yoo; Samantha Chao; Joseph Liu; Alena Cristina Jaime-Ramirez; Tae Jin Lee; Brian Hurwitz; Yuanqing Yan; Hongsheng Dai; Joseph C Glorioso; Michael A Caligiuri; Jianhua Yu; Balveen Kaur Journal: Clin Cancer Res Date: 2020-03-05 Impact factor: 12.531
Authors: Joshua D Bernstock; Nunzio Vicario; Li Rong; Pablo A Valdes; Bryan D Choi; Jason A Chen; Daniel DiToro; Diana S Osorio; Kara Kachurak; Florian Gessler; James M Johnston; T Prescott Atkinson; Richard J Whitley; Asim K Bag; G Yancey Gillespie; James M Markert; Dragan Maric; Gregory K Friedman Journal: Oncoimmunology Date: 2019-10-21 Impact factor: 8.110